Telbermin
Telbermin is a protein pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
708 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Macular degeneration | D008268 | EFO_0001365 | H35.30 | 14 | 26 | 13 | 10 | 32 | 87 |
| Macular edema | D008269 | — | — | 5 | 11 | 19 | 11 | 18 | 61 |
| Neoplasms | D009369 | — | C80 | 31 | 22 | 4 | 1 | 7 | 59 |
| Colorectal neoplasms | D015179 | — | — | 17 | 25 | 5 | 1 | 3 | 46 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 3 | 14 | 2 | 1 | 11 | 29 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 2 | 16 | 2 | 1 | 8 | 28 |
| Edema | D004487 | — | R60.9 | 2 | 6 | 11 | 3 | 7 | 28 |
| Wet macular degeneration | D057135 | EFO_0004683 | — | 4 | 10 | 5 | 2 | 9 | 27 |
| Retinal vein occlusion | D012170 | EFO_1001157 | H34.81 | 2 | 3 | 7 | 6 | 7 | 23 |
| Retinal diseases | D012164 | — | H35.9 | 1 | 3 | 5 | 3 | 9 | 19 |
Show 34 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carcinoma | D002277 | — | C80.0 | 21 | 46 | 9 | — | 18 | 87 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | 11 | 25 | 3 | — | 11 | 44 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 11 | 23 | 9 | — | — | 40 |
| Recurrence | D012008 | — | — | 7 | 29 | 2 | — | 4 | 39 |
| Non-small-cell lung carcinoma | D002289 | — | — | 15 | 20 | 4 | — | 2 | 34 |
| Adenocarcinoma | D000230 | — | — | 9 | 17 | 9 | — | — | 32 |
| Fallopian tube neoplasms | D005185 | — | — | 6 | 16 | 6 | — | — | 25 |
| Lung neoplasms | D008175 | — | C34.90 | 10 | 10 | 3 | — | 4 | 24 |
| Ovarian epithelial carcinoma | D000077216 | — | — | 8 | 13 | 4 | — | — | 23 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 10 | 10 | 3 | — | 2 | 22 |
Show 71 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Kidney neoplasms | D007680 | EFO_0003865 | C64 | 1 | 8 | — | — | 2 | 11 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 2 | 7 | — | — | 1 | 9 |
| Coronary artery disease | D003324 | — | I25.1 | 4 | 4 | — | — | 3 | 9 |
| Triple negative breast neoplasms | D064726 | — | — | 1 | 8 | — | — | — | 8 |
| Cystadenocarcinoma | D003536 | — | — | 4 | 4 | — | — | — | 8 |
| Carcinosarcoma | D002296 | — | — | 3 | 5 | — | — | — | 7 |
| Cholangiocarcinoma | D018281 | — | C22.1 | 2 | 6 | — | — | 1 | 7 |
| Leukemia | D007938 | — | C95 | 1 | 4 | — | — | 3 | 7 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 2 | 3 | — | — | 2 | 6 |
| Skin neoplasms | D012878 | EFO_0004198 | C44 | 1 | 5 | — | — | — | 6 |
Show 120 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Retinal neovascularization | D015861 | — | H35.05 | 2 | — | — | — | 2 | 4 |
| Healthy volunteers/patients | — | — | — | 4 | — | — | — | — | 4 |
| Hematologic neoplasms | D019337 | — | — | 2 | — | — | — | — | 2 |
| Anemia | D000740 | EFO_0004272 | D64.9 | 1 | — | — | — | 1 | 2 |
| Esophageal neoplasms | D004938 | — | C15 | 1 | — | — | — | 1 | 2 |
| Inverted papilloma | D018308 | — | — | 2 | — | — | — | — | 2 |
| Female genital neoplasms | D005833 | — | — | 2 | — | — | — | — | 2 |
| Pharyngeal neoplasms | D010610 | — | C14.0 | 2 | — | — | — | — | 2 |
| Urinary bladder neoplasms | D001749 | — | C67 | 1 | — | — | — | 1 | 2 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | — | — | — | — | 1 |
Show 43 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pre-eclampsia | D011225 | EFO_0000668 | O14 | — | — | — | — | 4 | 4 |
| Ectopic pregnancy | D011271 | — | O00 | — | — | — | — | 3 | 3 |
| Premature cardiac complexes | D005117 | — | I49.40 | — | — | — | — | 3 | 3 |
| Periodontal diseases | D010510 | — | K05.6 | — | — | — | — | 3 | 3 |
| Myopia | D009216 | EFO_0003927 | H52.1 | — | — | — | — | 2 | 2 |
| Intraocular pressure | D007429 | — | — | — | — | — | — | 2 | 2 |
| White dot syndromes | D000080363 | — | H30.14 | — | — | — | — | 2 | 2 |
| Low vision | D015354 | — | — | — | — | — | — | 2 | 2 |
| Endophthalmitis | D009877 | — | — | — | — | — | — | 2 | 2 |
| Disease progression | D018450 | — | — | — | — | — | — | 2 | 2 |
Show 106 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Telbermin |
| INN | telbermin |
| Description | Telbermin is a protein pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Protein |
| Drug class | growth factors: vascular endothelial growth factors |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2108557 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 22G76ZW50X (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 8,324 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use